LOIM
KRYS icon

Liberty One Investment Management’s Krystal Biotech KRYS Stock Holding History

Liberty One Investment Management’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13
Closed -$2.37K – 169
2024
Q3 		$2.37K Sell
13
-127
-91% -$24.5K ﹤0.01% 168
2024
Q2 		$26K Sell
140
-19
-12% -$3.19K ﹤0.01% 157
2024
Q1 		$28.3K Buy
159
+8
+5% +$1.11K ﹤0.01% 156
2023
Q4 		$18.7K Buy
151
+52
+53% +$5.77K ﹤0.01% 142
2023
Q3 		$11.5K Buy
99
+10
+11% +$1.22K ﹤0.01% 135
2023
Q2 		$10.4K Hold
89
– – ﹤0.01% 141
2023
Q1 		$7.13K Buy
+89
New +$6.99K ﹤0.01% 161
2021
Q4 		– Sell
-2,697
Closed -$141K – 146
2021
Q3 		$141K Sell
2,697
-72
-3% -$4.26K 0.02% 134
2021
Q2 		$188K Buy
2,769
+667
+32% +$46.6K 0.03% 134
2021
Q1 		$162K Buy
2,102
+545
+35% +$39.6K 0.03% 131
2020
Q4 		$93K Buy
1,557
+520
+50% +$26K 0.02% 129
2020
Q3 		$45K Buy
1,037
+527
+103% +$22.9K 0.01% 133
2020
Q2 		$21K Buy
+510
New +$24.5K ﹤0.01% 134

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Liberty One Investment Management's KRYS Position: Q4 2024 in Review

Liberty One Investment Management sold out of Krystal Biotech (KRYS) in Q4 2024, closing a stake of 13 shares — an estimated $2.37K sold.

Liberty One Investment Management first reported a position in KRYS in Q2 2020 and held it in 13 quarters. The position peaked at $188K in Q2 2021. 264 funds tracked by Wall St. Rank hold KRYS as of Q4 2024.

  • Liberty One Investment Management reported no remaining Krystal Biotech position as of Q4 2024 after selling out during the quarter.
  • Liberty One Investment Management sold 13 Krystal Biotech shares in Q4 2024, an estimated $2.37K.
  • Liberty One Investment Management first reported a position in Krystal Biotech in Q2 2020 and held it in 13 quarters.
  • Liberty One Investment Management's Krystal Biotech position peaked at $188K in Q2 2021.
  • 264 funds tracked by Wall St. Rank held Krystal Biotech as of Q4 2024.

Based on Liberty One Investment Management's 13F filing for Q4 2024, filed 16 Jan 2025.